4.4 Article

Emotion discrimination in humans: Its association with HSV-1 infection and its improvement with antiviral treatment

期刊

SCHIZOPHRENIA RESEARCH
卷 193, 期 -, 页码 161-167

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.schres.2017.08.001

关键词

Cognition; Herpes virus; HSV-1; Schizophrenia; Emotion; Memory; Valacyclovir

资金

  1. Department of Science and Technology, Government of India, Delhi [SR/CSI/63/2010(G)]
  2. Stanley Medical Research Institute, Bethesda MD [07R-1712, 07R-1690]
  3. NIH, Bethesda MD [MH63480, D43 TW009114]
  4. FOGARTY INTERNATIONAL CENTER [D43TW008302, D43TW006167, D43TW009114] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093745, R01MH056242, U01MH085269, R10MH056242, R01MH063480, R01MH093246, RC2MH089859] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Background: Herpes simplex virus, type 1 (HSV-1) infects over 3.4 billion people, world-wide. Though it can cause encephalitis, in the vast majority it is asymptomatic, with lifelong latent infection in neurons. HSV-1 infected individuals have greater cognitive dysfunction than uninfected individuals, particularly persons with schizophrenia - even without encephalitis. We investigated whether HSV-1 related cognitive dysfunction is progressive or remediable. Methods: In a prospective naturalistic followup sample (PNFU), temporal changes in cognitive functions were analyzed in relation to baseline HSV-1 infection in persons with/without schizophrenia (N= 226). Independently, in a randomized controlled trial (RCT), HSV-1 infected, clinically stabilized SZ outpatients received Valacyclovir (VAL, an HSV-1 specific antiviral, 1.5 G twice daily for 16 weeks) or placebo (PLA) added to standard antipsychotic treatment, using a stratified randomization design, following placebo run-in (N= 67). In both samples, HSV-1 infection (seropositivity) was estimated using serum IgG antibodies. Clinical evaluations were blinded to HSV-1 or treatment status. Standardized Z scores for accuracy on eight cognitive domains were analyzed for temporal trajectories using generalized linear models (PNFU) and VAL/PLA differences compared with intent to treat analyses (RCT). Results: PNFU: At baseline, HSV-1 infected participants had significantly lower accuracy scores for Emotion Identification and Discrimination (EMOD), Spatial memory and Spatial ability, regardless of SZ diagnosis (p=0.025, 0.029, 0.046, respectively). They also had significantly steeper temporal worsening for EMOD (p = 0.03). RCT: EMOD improved in VAL-treated patients (p= 0.048, Cohen's d = 0.43). Conclusions: A proportion of age related decline in EMOD is attributable to HSV-1 infection. (c) 2017 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据